Medicine
Dexilant 30 mg delayed-release capsule
Dexilant 30 mg delayed-release capsule is a prescription medicine containing Dexlansoprazole for oral use, marketed by Takeda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F), excursions permitted to 15 to 30°C (59 to…
Key facts
- Active ingredient (INN)
- Dexlansoprazole
- Brand
- Dexilant
- Strength
- 30 mg
- Dosage form
- Delayed-release capsule
- Route
- Oral
- Packs
- 7 capsules, 5 blister pack, 1 bottle and 4 more
- Marketing authorisation holder
- Takeda Pharmaceuticals
- Manufacturer
- Takeda Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F), excursions permitted to 15 to 30°C (59 to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A02BC06 Dexlansoprazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 April 2010
- Identifiers
- RxCUI 833204, 833213, 902624 +1DailyMed set ID 9819f033-3bbe-442e-8e92-45fec77b237dNDC 64764-171Application NDA022287
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 7 capsule, delayed release in 1 bottle | 64764-171-00 | Takeda Pharmaceuticals | 12 April 2010 |
| 5 blister pack in 1 tray / 4 capsule, delayed release in 1 blister pack | 64764-171-01 | Takeda Pharmaceuticals | 12 April 2010 |
| 1 bottle in 1 carton / 5 capsule, delayed release in 1 bottle | 64764-171-03 | Takeda Pharmaceuticals | 12 April 2010 |
| 10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack | 64764-171-11 | Takeda Pharmaceuticals | 12 April 2010 |
| 1000 capsule, delayed release in 1 bottle | 64764-171-19 | Takeda Pharmaceuticals | 12 April 2010 |
| 30 capsule, delayed release in 1 bottle | 64764-171-30 | Takeda Pharmaceuticals | 12 April 2010 |
| 90 capsule, delayed release in 1 bottle | 64764-171-90 | Takeda Pharmaceuticals | 12 April 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 January 2009 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dexlansoprazole 30 mg delayed-release capsule.
Other strengths and forms of Dexlansoprazole
Clinical summary
Dexlansoprazole is a proton pump inhibitor indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE), among other approved uses. It is available as delayed-release capsules for oral use. MedsAcross supplies Dexlansoprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DexlansoprazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dexilant prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Dexilant 30 mg delayed-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.